Thus, researchers propose that growth hormone secretagogues like Ipamorelin might elevate fat levels through mechanisms that do not involve growth hormone directly, possibly by enhancing food intake
The SELECT Cardiovascular Outcome Trial The SELECT trial (N=17,604) enrolled adults with established cardiovascular disease, BMI 27, and no diabetes
However, many patients with NAFLD have comorbid conditions for which these medications are appropriately indicated, potentially providing dual metabolic and hepatic benefits
Standardized dosing protocols, validated outcome measures, and comprehensive safety monitoring would establish the evidence base necessary for informed clinical decision-making
Selenium supplementation in patients with hashimotos thyroiditis: results of a randomized controlled trial
The combination of GLP-1R agonists with each other has not been studied previously, suggesting that due to their similar mode of action, there would not be an enhancement in therapy from this combination